Works matching DE "REFRACTORY anemia"


Results: 49
    1
    2
    3

    Biosimilar epoetin α is as effective as originator epoetin-α plus liposomal iron (Sideral®), vitamin B12 and folates in patients with refractory anemia: A retrospective real-life approach.

    Published in:
    Molecular & Clinical Oncology, 2015, v. 3, n. 4, p. 41, doi. 10.3892/mco.2015.555
    By:
    • GIORDANO, GIULIO;
    • MONDELLO, PATRIZIA;
    • TAMBARO, ROSA;
    • PERROTTA, NICOLA;
    • D'AMICO, FABIO;
    • D'AVETA, ANTONIETTA;
    • BERARDI, GIUSEPPE;
    • CARABELLESE, BRUNO;
    • PATRIARCA, ANDREA;
    • CORBI, GRAZIA MARIA;
    • DI MARZIO, LUIGI;
    • LICIANCI, ANTONIETTA;
    • BERARDI, DONATA;
    • DI LULLO, LIBERATO;
    • DI MARCO, ROBERTO
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Acquired Refractory Iron Deficiency Anemia.

    Published in:
    Mediterranean Journal of Hematology & Infectious Diseases, 2021, v. 13, n. 1, p. 1, doi. 10.4084/MJHID.2021.028
    By:
    • De Amicis, Margherita Migone;
    • Rimondi, Alessandro;
    • Elli, Luca;
    • Motta, Irene
    Publication type:
    Article
    15

    Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in refractory ascites: Post-marketing surveillance results.

    Published in:
    PLoS ONE, 2017, v. 12, n. 5, p. 1, doi. 10.1371/journal.pone.0177303
    By:
    • Hanafusa, Norio;
    • Isoai, Ayako;
    • Ishihara, Tomoaki;
    • Inoue, Tetsuya;
    • Ishitani, Ken;
    • Utsugisawa, Taiju;
    • Yamaka, Toshihiko;
    • Ito, Tetsuya;
    • Sugiyama, Hiroshi;
    • Arakawa, Atsushi;
    • Yamada, Yosuke;
    • Itano, Yasuo;
    • Onodera, Hirokazu;
    • Kobayashi, Ryosuke;
    • Torii, Naoko;
    • Numata, Toyoko;
    • Kashiwabara, Taihei;
    • Matsuno, Yoshihiro;
    • Kato, Michio
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22

    Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts.

    Published in:
    Annals of Hematology, 2015, v. 94, n. 4, p. 565, doi. 10.1007/s00277-014-2252-4
    By:
    • Font, Patricia;
    • Loscertales, Javier;
    • Soto, Carlos;
    • Ricard, Pilar;
    • Novas, Carolina;
    • Martín-Clavero, Estela;
    • López-Rubio, Montserrat;
    • Garcia-Alonso, Luis;
    • Callejas, Marta;
    • Bermejo, Alfredo;
    • Benavente, Celina;
    • Ballesteros, Mónica;
    • Cedena, Teresa;
    • Calbacho, María;
    • Urbina, Raquel;
    • Villarrubia, Jesús;
    • Gil, Santiago;
    • Bellón, José;
    • Diez-Martin, José;
    • Villegas, Ana
    Publication type:
    Article
    23
    24
    25
    26
    27
    28

    Ghosal type hematodiaphyseal dysplasia.

    Published in:
    Indian Pediatrics, 2016, v. 53, n. 4, p. 347, doi. 10.1007/s13312-016-0851-y
    By:
    • Jeevan, Amrit;
    • Doyard, Mathilde;
    • Kabra, Madhulika;
    • Daire, Valerie;
    • Gupta, Neerja
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37

    A phase I/II randomized trial of clofarabine or fludarabine added to idarubicin and cytarabine for adults with relapsed or refractory acute myeloid leukemia.

    Published in:
    Leukemia & Lymphoma, 2018, v. 59, n. 4, p. 813, doi. 10.1080/10428194.2017.1349907
    By:
    • Short, Nicholas J.;
    • Kantarjian, Hagop;
    • Ravandi, Farhad;
    • Garcia-Manero, Guillermo;
    • Pemmaraju, Naveen;
    • Daver, Naval G.;
    • Borthakur, Gautam;
    • Jain, Nitin;
    • Konopleva, Marina;
    • Estrov, Zeev;
    • Kadia, Tapan M.;
    • Wierda, William G.;
    • DiNardo, Courtney D.;
    • Brandt, Mark;
    • Cortes, Jorge E.;
    • Jabbour, Elias;
    • Huang, Xuelin;
    • Xiao, Lianchun;
    • Plunkett, William;
    • Gandhi, Varsha
    Publication type:
    Article
    38
    39
    40

    Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. A multicenter phase I–II GIMEMA trial.

    Published in:
    Leukemia & Lymphoma, 2017, v. 58, n. 7, p. 1640, doi. 10.1080/10428194.2016.1258698
    By:
    • Mauro, Francesca R.;
    • Carella, Angelo M.;
    • Molica, Stefano;
    • Paoloni, Francesca;
    • Liberati, Anna M.;
    • Zaja, Francesco;
    • Belsito, Valeria;
    • Cortellezzi, Agostino;
    • Rizzi, Rita;
    • Tosi, Patrizia;
    • Spriano, Mauro;
    • Ferretti, Antonietta;
    • Nanni, Mauro;
    • Marinelli, Marilisa;
    • De Propris, Maria S.;
    • Orlando, Sonia M.;
    • Vignetti, Marco;
    • Cuneo, Antonio;
    • Guarini, Anna R.;
    • Foà, Robin
    Publication type:
    Article
    41
    42
    44

    Low Beclin-1 expression predicts improved overall survival in patients treated with immunomodulatory drugs for multiple myeloma and identifies autophagy inhibition as a promising potentially druggable new therapeutic target: an analysis from The Austrian Myeloma Registry (AMR)

    Published in:
    Leukemia & Lymphoma, 2016, v. 57, n. 10, p. 2330, doi. 10.3109/10428194.2016.1144880
    By:
    • Willenbacher, Wolfgang;
    • Thangavadivel, Shanmugapriya;
    • Greil, Richard;
    • Willenbacher, Ella;
    • Weger, Roman;
    • Manzl, Claudia;
    • Jöhrer, Karin;
    • Brunner, Andrea
    Publication type:
    Article
    45

    Romidepsin in relapsed/refractory T-cell lymphomas: Italian experience and results of a named patient program.

    Published in:
    Leukemia & Lymphoma, 2016, v. 57, n. 10, p. 2370, doi. 10.3109/10428194.2015.1137292
    By:
    • Zinzani, Pier Luigi;
    • Pellegrini, Cinzia;
    • Cerciello, Giuseppe;
    • Monaco, Federico;
    • Volpetti, Stefano;
    • Peli, Annalisa;
    • Angelucci, Emanuele;
    • Corradini, Paolo;
    • Cox, Maria Christina;
    • Guarini, Attilio;
    • Musso, Maurizio;
    • Bresciani, Paola;
    • Amato, Gabriella;
    • Billio, Atto;
    • Caparrotti, Giuseppe;
    • Figuera, Amalia;
    • Nassi, Luca;
    • Gaudio, Francesco;
    • Grossi, Alberto;
    • Onida, Francesco
    Publication type:
    Article
    46
    47
    48
    49